Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling
Multiple myeloma (MM) has a propensity to develop preferentially in bone and form bone-destructive lesions. MM cells enhance osteoclastogenesis and bone resorption through activation of the RANKL–NF-κB signaling pathway while suppressing bone formation by inhibiting osteoblastogenesis from bone marr...
Main Authors: | Takeshi Harada, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4441 |
Similar Items
-
Pathogenesis and treatment of multiple myeloma bone disease
by: Masahiro Hiasa, et al.
Published: (2021-11-01) -
Sensory nerves: A driver of the vicious cycle in bone metastasis?
by: Toshiyuki Yoneda, et al.
Published: (2021-10-01) -
Effect of TAK-242 on Proliferation and Apoptosis of Human Multiple Myeloma Cells
by: DUAN Pingping, et al.
Published: (2019-04-01) -
Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
by: Jelena Bila, et al.
Published: (2021-08-01) -
PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01)